Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Piperazine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115368317A details a novel salting-out method for 1-(2,3-dichlorophenyl)piperazine hydrochloride, ensuring low dimer impurities and reduced solvent usage.
Novel patent CN114478407B enables solid-state purification of chiral homopiperazine. Reduces costs and enhances supply chain reliability for pharmaceutical manufacturing.
Patent CN106995413A reveals high-ee iridium-catalyzed hydrogenation for chiral piperazines, offering cost-effective and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN111187264A introduces a resin-catalyzed cyclization for mirtazapine, eliminating sulfuric acid waste and simplifying purification for reliable pharmaceutical intermediate supply.
Patent CN101602751A reveals a cost-effective, aqueous-based synthesis for Cinepazide Maleate intermediates, offering significant supply chain and safety advantages.
Patent CN107868054A reveals a novel catalyst method for azoxystrobin intermediate, offering higher yield and reduced reaction time for reliable agrochemical intermediate supply chains.
Patent CN113185478B reveals a novel ethylenediamine-based route for N-Boc-piperazine, offering superior purity and significant cost reduction for pharmaceutical manufacturing.
Patent CN1680374A reveals optimized hydrolysis for mirtazapine intermediates, offering significant cost reduction and scalable manufacturing for pharmaceutical supply chains.
Patent CN111995569B details a novel CuI catalyzed route reducing costs and improving purity for scalable pharmaceutical intermediates manufacturing supply chains.
Patent CN102060811A introduces a direct one-step synthesis for monosulfonyl piperazine, eliminating complex protection steps for significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113185478A reveals a novel ethylenediamine-based route for N-Boc-piperazine, offering superior purity and cost reduction in pharmaceutical intermediate manufacturing.
Novel patent CN117088829A offers high-yield synthesis for antifungal intermediates. Ensures supply chain stability and cost reduction in API intermediate manufacturing.
Discover advanced processes for preparing cyclopenta[d]pyrimidin-4-yl piperazine compounds. Enhance supply chain reliability and reduce manufacturing costs for AKT inhibitors.
Patent CN101891794B details a novel ursolic acid piperazine derivative with superior antitumor activity. Discover scalable synthesis routes and cost-effective manufacturing strategies.
Patent CN102391169B offers high-purity BPH intermediate synthesis. Ether solvent method ensures safety and scalability for pharmaceutical supply chains.
Patent CN108473451A reveals metal-free synthesis for high-purity pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability.
Novel synthesis route for aPKC inhibitor intermediates ensures high purity and scalable production for pharmaceutical supply chains.
Patent CN104797563B reveals improved in-situ synthesis of activated fumarate intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical excipient manufacturing.
Patent CN101735201B details a high-yield Piribedil synthesis via Blanc chloromethylation and mild N-alkylation, offering cost-effective API intermediate manufacturing solutions.
Discover how nickel-catalyzed C-C coupling enables high-yield synthesis of linear olefin benzhydryl piperazine, reducing production costs and supply chain risks for pharmaceutical intermediates.